Genomic personalized medicine and surgery is a novel approach to health care that tailors a patient's medical treatment to their genetic makeup. The enhanced approach is the consequence of better understanding of the human genome and strategies for using that information by physicians in medical and surgical management of their patients. These can be used to further identify a variety of complicated disorders and lead to the identification of more specialised treatments based on genomic profiling, removing some conventional medications that may be ineffective or have adverse side effects in specific patient populations.
MARKET SCOPE
The "Global Genomics Personalized Health Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the genomics personalized health market with detailed market segmentation by technology, test type and end user. The report provides key statistics on the market status of the leading genomics personalized health market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on technology the market is segmented as, NGS platforms, RT-PCR, microarray, genetic analyzers.
- Based on test type the market is segmented as, oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, others.
- Based on end user the market is segmented as, academics & research institutes, diagnostic centers, others.
MARKET DYNAMICS
Drivers:
- Growing prevalence of chronic diseases such as cancer is the key driving factor for the market growth.
- Technological advancements in biopharmaceutical and biotechnology industries.
- Growing emphasis on genomic based research and growing funding for the same.
Restraints:
- However, presence of complex regulatory framework is likely to hamper market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The genomics personalized health market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the genomics personalized health market in these regions.
IMPACT OF COVID-19 ON GENOMICS PERSONALIZED HEALTH MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the genomics personalized health market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from genomics personalized health market are anticipated to lucrative growth opportunities in the future with the rising demand for genomics personalized health in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the genomics personalized health market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- QIAGEN
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Invitae Corporation
- Genetic Technologies Limited
- Lonza
- Interleukin Genetics, Inc
- DNAGenotek